Company news
Assembly Biosciences, Inc. news in 2026
Assembly Biosciences, Inc.'s news releases, calls and decks from 2026, newest first.
Assembly Biosciences to Participate in Upcoming Investor Conferences
November 2, 2026
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
October 29, 2026
Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026
October 5, 2026
Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference
September 10, 2026
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
September 8, 2026
Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates
August 13, 2026
Assembly Biosciences Announces Upcoming Investor Conference Presentations
May 28, 2026
Assembly Biosciences Announces the Closing of its Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
May 26, 2026
Assembly Biosciences Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants
May 22, 2026
Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases
May 22, 2026
Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
May 13, 2026
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
May 11, 2026
Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
May 7, 2026
Assembly Biosciences Highlights Presentations on Positive Phase 1b Data for ABI-5366 and ABI-1179 in Recurrent Genital Herpes at ESCMID Global 2026
April 9, 2026
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights
March 18, 2026
Decks in 2026
- Investor Presentation (September 2026)
Investor deck · 37 slides · September 2026